Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

Part of paid clinical trials in Minneota, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT07075731
Status
Recruiting
Apply to this trial

Conditions

  • Cancer Screening
  • Gender Diverse Populations
  • Transgender

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    Observational study

Study Details

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Key Dates

Start date
Jun 30, 2025
Status verified
Jul 2025
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Standard of Care Cancer Screening
  • Arm: FDA approved self swab
  • Arm: Mock self swab

Primary Outcome Measure

Rates of cervical cancer screening and endometrial sampling in TGD individuals [ Time Frame: Month 36 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneotaMinnesota55455
Maria Bunch
[email protected]
612-624-2018

Find similar trials in Minneota, MN

By research site
University of Minnesota· Minneota, MN

Related Studies